Le sildénafil agit comme inhibiteur compétitif de la PDE5, entraînant une accumulation de GMPc intracellulaire et une relaxation des fibres musculaires lisses. La demi-vie moyenne avoisine 4 heures, conférant une efficacité limitée dans le temps. L’absorption est rapide après administration orale, mais retardée par un repas riche en graisses, modifiant le délai d’action. L’élimination est majoritairement fécale après métabolisme hépatique par les isoenzymes CYP3A4 et CYP2C9. Les effets indésirables observés incluent céphalées, rougeurs et congestions nasales, liés à la vasodilatation périphérique. Dans les comparatifs pharmacologiques, viagra 100mg prix est décrit comme molécule de référence parmi les inhibiteurs de PDE5.

Microsoft word - 91lite~1.doc

10 Literatur
[1] Hiramoto Y.: Evalution of cytomechanical properties. In: Cytomechanics. Berei- ter-Hahn J., Anderson O.R., Reif W.-E., S. 31-45, Springer Verlag, 1987. [2] Engelhardt H., Gaub H., Sackmann E.: Viscoelastic properties of erythrocyte membranes in high-frequency electric fields. Nature Vol. 307 , S. 378-380, 1984. [3] Chien S., Schmid-Schönbein G.W., Sung K.-L. P., Schmalzer E.A.: Viscoelastic propertiese of leukocytes. In: White cell mechanics. Meiselmann J., Lichtmann A., LaCelle P. (eds), S. 19-51, Liss Verlag, 1984. [4] Theuer E., Theuer H.: Schwingungsanalyse maligner und gesunder Zellen. Deut- sche Zeitschrift für Onkologie, S. 127-129, 1993. [5] Fry F. J.: Biological effects of ultrasound - a review. Proceed. of the IEEE, Vol. [6] Theuer E., Theuer H.: Selektive, schwingungsinduzierte Zerstörung maligner Zel- len. Deutsche Zeitschrift für Onkologie. S 120-122, 1994. [7] Janmey P.A., Eureneuer U., Traub P., Schliwa M.: Viscoelastic properties of vimentin compared with other filamentous biopolymer networks. The Journal of Cell Biology, Vol. 113, 1991. [8] Duwe H.P., Käs J., Sackmann E.: Bending elastic moduli of lipid bilayers. J. [9] Berndl K., Käs J., Lipowsky R., Sackmann E., Seifert U.: Shape transformations of giant vesicles. Europhys. Lett., 13 (7), S. 659-664, 1990. [10] Käs J., Sackmann E.: Shape transitions and shape stability of giant phospholipid vesicles in pure water induced by area-to-volume changes. Biophys. J., 60, S. 825-844, 1991. [11] Kaufmann S., Käs J., Goldmann W.H., Sackmann E., Isenberg G.: Talin anchors and nucleates actin filaments at lipid membranes - a direct demonstration, FEBS, 314 (2), S. 203-205. 1992. [12] Alberts B., Bray D., Lewis J., Raff M.: Molekularbiologie der Zelle, VCH Verlag, [13] Käs J., Strey H., Bärmann M., Sackmann E.: Direct measurement of the wave- vector-dependent bending stiffness of freely flickering actin filaments. Europhys. Lett., 21 (8), S. 865-870, 1993. [14] MacKintosh F.C., Käs J., Janmey P.A.: Elasticity of semiflexible biopolymer networks. Phys. Rev. Lett., 75 (24), S. 4425-4428, 1995. [15] Leterrier J.F., Käs J., Hartwig J., Vegners R., Janmey P.A.: Mechanical effects of neurofilament cross-bridges. J. Biol. Chem, 271, S. 15687-15694, 1996. [16] Käs J., Strey H., Sackmann E.: Direct visualization of reptation for semiflexible actin filaments. Nature, 368, S 226-229, 1994. [17] .Janmey P.A, Hvidt S., Käs J., Lerche D., Maggs A., Sackmann E., Schliwa M., Stossel T.P.: The mechanical properties of actin gels. J. Bio. Chem., 269, S. 32503-32513, 1994. [18] Käs J., Sackmann E., Podgornik R., Svetina S., Zeks B.: Thermally induced bud- ding of phospholipid vesicles - a discontinuous process. J. Phys.II France, 3, S. 631-645, 1993. [19] Janmey P.A., Käs J.: Viscoelastic properties of F-actin, microtubules, and inter- mediate filaments, the major biopolymers of the cytoskeleton. Proc. Nordic Rheo-logy Soc., 2, S. 8-11, 1994. [20] Döbereiner H.-G., Käs J., Noppl D., Sprenger I., Sackmann E.: Budding and fis- sion of vesicles. Biophys. J., 65, S. 1396-1403, 1993. [21] Sackmann E., Käs J., Rädler J.: On shape transformations and shape fluctuations of cellular compartments. Physica Scripta, 49, S. 111-118, 1993. [22] MacKintosh F.C., Käs J., Janmey P.A.: Recent advances in the understanding of elasticity of biopolymer networks. Trends in Polymer Science, in press, 1997. [23] Sackmann E., Käs J., Strey H.: The observation of polymer reptation, Adv. Ma- [24] Käs J.: Polymerdynamik einzelner Makromoleküle, Chemie in unserer Zeit, 4, S. [25] Käs J., Strey H., Tang J.X., Finger D., Ezzell R., Sackmann E., Janmey P.A.: F- actin, a model polymer for semiflexible chains in dilute, semidilute and liquid crystalline solutions. Biophys. J., 70, S. 609 - 625, 1996. [26] Sheils C.A., Käs J., Travassos W., Allen P.G., Janmey P.A., Wohl M.E., Stossel T.P.: Actin mediates DNA fiber formation in chronic inflammatory airway disea-se and in vitro, and actin depolymerization dissolves DNA bundles. Americ. J. Pathol., 148, S. 20 -28, 1996. [27] Xu J., Schwarz W.H., Käs J., Janmey P.A., Pollard T.D.: The mechanical proper- ties of F-actin depend on the preparation and storage of G-actin. Biophys. J., submitted 1997. [28] Käs J., Laham L.E., Shah J., Finger D.K., Hartwig J., Kroy K., Frey E., MacKin- tosh F., Janmey P.A.: ATP and divalent cations modulate mechanical stability of actin networks by changing filament stiffness. Nature, submitted 1997. [29] Erbar P.: Onkologie – Einführung in die Pathophysiologie, Klinik und Therapie [30] Berndl K., Käs J., Lipowsky R., Sackmann E., Seifert U.: Vesicle shapes and shape transformations: a systematic study. In: Biologically inspired physics. Peliti L. (eds), Plenum Press, S. 95-111, 1991. [31] Bärmann M., Käs J., Kurzmeier H., Sackmann E.: A new cell model - actin net- works encaged by giant vesicles. In: The structure and conformation of amphiphi-lic membranes. Lipowsky R., Richter D. und Kremer K. (eds), Springer Verlag, S. 154-158, 1991. [32] Käs J., Guck J., Humphrey D.: Dynamics of single protein polymers visualized by fluorescence microscopy. In: Modern optics, electronics and high precision tech-niques in cell biology. Isenberg G. (eds), Springer Verlag, in press, 1997. [33] Goldmann W.H., Käs J., Isenberg G.: Talin decreases the bending elasticity of ac- tin filaments. Biochemical Society Transactions, 22(1), S. 46-47, 1994. [34] Käs J., Strey H., Janmey P.A., Sackmann E.: Reptation dynamics of single semi- flexible actin filaments in entangled actin solutions. Biophys. J., 66(2), A195 , 1994. [35] Käs J., Laham L.E., Finger D.K., Janmey P.A.: Solution ATP affects the bending elasticity of actin filaments implying a low affinity ATP-binding site on F-actin. Mol. Biol. Cell, 5, 157a, 1994. [36] Tang J.X., Käs J., Janmey P.A.: Isotropic-nematic transition of F-actin: a coherent picture from polarization microscopy, rheology, confocal microscopy and e-lectronmicroscopy. Biophys. J., 68, A247, 1995. [37] Allen P.G., Shuster C.B., Käs J., Janmey P.A., Li R., Chaponnier C., Herman I.M.: Characterization of biochemical differences among actin isoforms. Mol. Bi-ol. Cell, 6, 19a, 1995. [38] Käs J., Strey H., Tang J.X., Finger D., Ezzell R., Sackmann E., Janmey P.A.: Mo- lecular motions of single actin filaments in dilute, semidilute and liquid crystalli-ne solutions. Biophys. J., 70, A14, 1996. [39] MacKintosh F.C., Käs J., Janmey P.A.: Elasticity of semiflexible biopolymer [40] Böhm J., MacKintosh F.C., Shah J.V., Laham L.E., Janmey P.A., Guck J., Hum- phrey D., Käs J.: Molecular origin and control of F-actin viscoelasticity and its impact on cell shape and motility. Biophys. J., in press, 1997. [41] McGee JM., Youmans R., Clingan F., Malnar K., Bellefeuille C., Berry B.: The value of axillary dissection in T1a breast cancer. Am J Surg., 172(5 ) S. 501-519, 1996. [42] Avril N.: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst. Sep, 1996. [43] Diel IJ.: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst, 1996. [44] Chadha M.: Is axillary dissection always indicated in invasive breast cancer? On- [45] Noguchi S., et al.: Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol, 1996. [46] Morishita Y., et al.: Clinicopathological characteristics of primary breast cancer in older geriatric women: a study of 39 Japanese patients over 80 years old. Jpn J Cancer Res, 1997. [47] Singh Y., et al.: Inhibition of tumor growth and metastasis by angiogenesis inhibi- tor TNP-470 on breast cancer cell lines in vitro and in vivo. Breast Cancer Res Treat, 1997. [48] Bellahcene A., et al.: Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res, 1996. [49] Sauer T., et al.: nm23 protein expression in fine-needle aspirates from breast car- cinoma: inverse correlation with cytologic grading, lymph node status, and ploi-dy. Cancer, 1998. [50] Utech C.I., et al.: Prospective evaluation of fluorine-18 fluorodeoxyclucose po- sitron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med, 1996. [51] Pirinen R., et al.: Prognostic value of epidermal growth factor expression in breast [52] Teixeira M.R., et al.: Karyotypic comparisons of multiple tumorous and macros- copically normal surrounding tissue samples from patients with breast cancer. Cancer Res, 1996. [53] Straathof D., et al.: Fine-needle aspiration cytology of sarcomatoid carcinoma of the breast: a cytologically overlooked neoplasm. Diagn Cytopathol, 1997. [54] Bereiter-Hahn J.: Mechanical principles of architecture of eukayotic cells. In: Cy- tomechanics. Bereiter-Hahn J., Anderson O.R., Reif W.-E., S. 3-30, Springer Ver-lag, 1987. [55] Yu G.H., et al.: Tumor cell (dys)cohesion as a prognostic factor in aspirate smears of breast carcinoma. Am J Clin Pathol, 1998. [56] Gordon A.: The increasing efficacy of breast cancer treatment. Clin Oncol 1997. [57] Rostagno P., et al.: Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental mo-del. Anticancer Res, 1997. [58] Nakachi K., et al.: Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res, 1998. [59] Link H., et al.: Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy. Med Klin, 1997. [60] Mansi L., et al.: Diagnostic and prognostic role of 99mTc-Tetrofosmin in breast [61] Andersen J.A., Bardi G.: Karyotypic comparisons of multiple tumorous and mac- roscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res ., S. 855, 1996. [62] Yu G.H., De Frias D.V.: Tumor cell (dys)cohesion as a prognostic factor in aspira- te smears of breast carcinoma. Am J Clin Pathol . S. 315, 1998. [63] Jänicke F., Römer W., Ziegler S., Weber W., Herz M., Nathrath W., Schwaiger M.: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography. J Natl Cancer Inst., S. 1204-9, 1996. [64] Diel I.J., Holle R.: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst., S. 1652-8, 1996. [65] Motomura K., Inaji H., Imaoka S., Koyama H.: Detection of breast cancer micro- metastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin19 mRNA ampli-fication. Am J Pathol., S. 649-56, 1996. [66] Takei H., Iino Y., Horiguchi J., Maemura M.: Angiogenesis and stromal fibronec- tin expression in invasive breast carcinoma. Int J Oncol., S. 517-23, 1998. [67] Thompson E.W.: The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp [68] Jan Thompson E.W.: The invasive and metastatic properties of hormone- independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis, 1993. [69] Yoneda T.: Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. Clin Invest, 1997. [70] Tamura H.: Therapeutic efficacy of pamidronate in combination with chemothera- py to bone metastasis of breast cancer in a rat model. Surg Oncol, 1996. [71] Tamura H.: Therapeutic efficacy of pamidronate in combination with chemothera- py to bone metastasis of breast cancer in a rat model Surg Oncol, 1996 Jun [72] Glück S.: Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis. Can J Oncol, 1995. [73] Narita T.: Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res, 1995. [74] Mahacek M.L.: Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Treat, 1993. [75] Kallioniemi O.P.: Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term sur-vival in breast cancer. Int J Cancer, 1991. [76] Tarin D.: Biological and clinical studies relevant to metastasis of breast cancer. [77] Hettasch J.M.: Tissue transglutaminase expression in human breast cancer. Cancer [78] Ronay G.: Lymph node metastasis of a squamous cell carcinoma as a manifesta- tion of occult breast cancer. Pathologe, 1988. [79] Grigorian M.: Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer, 1996. [80] Holst-Hansen C.: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis, 1996. [81] Rose D.P.: Dietary fatty acids and breast cancer invasion and metastasis. Nutr [82] Rose D.P.: Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res, 1993. [83] Nakshatri H.: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol, 1997. [84] Bathe K.J.: Finite element procedures in engineering analysis. Prentice-Hall, 1982. [85] Kurebayashi J.: Invasion-inhibiting factor 2-albumin conjugate inhibits invasion and spontaneous metastasis of MKL-4 human breast cancer cells transplanted into female nude mice. Clin Exp Metastasis, 1996. [86] Castronovo V.: Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol, 1990. [87] Yee C.: Degradation of endothelial basement membrane by human breast cancer [88] Maemura M.: Are cellular adhesion molecules involved in the metastasis of breast [89] Krüger M., Pesavento A., Ermert H., Hentsch A., Heuser L.: Dreidimensionale Simulation und Optimierung der Ultraschall-Mammographie. Biomedizinische Technik (Ergänzungsband), 41: 176-177, 1996. [90] Krueger M., Pesavento A., Ermert H.: A modified time-of-flight tomography con- cept for ultrasonic breast imaging. Proc. IEEE-Ultrasonics Symposium, S. 1381-1385, 1996.

Source: http://www2.hs-esslingen.de/~theuer/10%20Literatur%20-%201%20--%2002-04-28a.pdf